188 related articles for article (PubMed ID: 2516891)
1. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
Sundal E; Kaeser U
Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
Frenken LA; Verberckmoes R; Michielsen P; Koene RA
Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
[TBL] [Abstract][Full Text] [Related]
4. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.
Van Damme-Lombaerts R; Broyer M; Businger J; Baldauf C; Stocker H
Pediatr Nephrol; 1994 Jun; 8(3):338-42. PubMed ID: 7917862
[TBL] [Abstract][Full Text] [Related]
5. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile.
Sundal E; Businger J; Kappeler A
Nephrol Dial Transplant; 1991; 6(12):955-65. PubMed ID: 1798595
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
8. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
[TBL] [Abstract][Full Text] [Related]
9. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
Winearls CG
Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
[TBL] [Abstract][Full Text] [Related]
12. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
[TBL] [Abstract][Full Text] [Related]
13. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC
Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424
[TBL] [Abstract][Full Text] [Related]
15. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis.
Sobh MA; el-Tantawy AE; Said E; Atta MG; Refaie A; Nagati M; Ghoneim M
Scand J Urol Nephrol; 1992; 26(1):65-9. PubMed ID: 1631509
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients.
Nephron; 1992; 61(4):399-403. PubMed ID: 1501735
[TBL] [Abstract][Full Text] [Related]
17. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous.
Hörl WH
Acta Haematol; 1992; 87 Suppl 1():16-9. PubMed ID: 1574961
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
Li WY; Chu TS; Huang JW; Wu MS; Wu KD
J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
20. Anaemia and its response to treatment with recombinant human erythropoietin in chronic kidney disease patients.
Abdu A; Arogundade F; Adamu B; Dutse AI; Sanusi A; Sani MU; Mijinyawa MS; Akinsola A; Borodo MM
West Afr J Med; 2009; 28(5):295-9. PubMed ID: 20383832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
